当前位置：首页 > 文献互助 > 互助详情

期刊论文A causation theory of visitor-resident irritants: Methodology and research inferences复制

用户CBKkXJHWL1xk 6个月前 166 已关闭

DOI:复制

文献链接: https://www.scirp.org/reference/referencespapers?referenceid=3380728复制

其他信息:

上一篇：Free Energy of Collagen-Mimetic Peptide Dimerization and Implications for Fibrillization

下一篇：Review of Semiconductor Flash Memory Devices for Material and Process Issues

互助时间线

2026-01-18 11:43:14 [关闭求助]

楼主用户CBKkXJHWL1xk关闭了求助

2026-01-17 20:34:13 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 4分钟前

等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 20分钟前

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 32分钟前

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 38分钟前

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 39分钟前

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 48分钟前

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 54分钟前

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 56分钟前

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前

Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前